A case of sporotrichosis caused by different Sporothrix brasiliensis strains: mycological, molecular, and virulence analyses.


Journal

Memorias do Instituto Oswaldo Cruz
ISSN: 1678-8060
Titre abrégé: Mem Inst Oswaldo Cruz
Pays: Brazil
ID NLM: 7502619

Informations de publication

Date de publication:
2019
Historique:
received: 18 07 2019
accepted: 25 09 2019
entrez: 24 10 2019
pubmed: 24 10 2019
medline: 30 10 2019
Statut: epublish

Résumé

Sporotrichosis is a subcutaneous mycosis caused by dimorphic pathogenic fungi belonging to the Sporothrix genus. Pathogenic Sporothrix species typically produce melanin, which is known to be a virulence factor. The aim of this study was to perform phenotypic, genotypic, and virulence analyses of two distinct Sporothrix brasiliensis strains isolated from the same lesion on a patient from Rio de Janeiro. Genotypic analyses by partial sequencing of the calmodulin, β-tubulin, and chitin synthase genes, as well as polymerase chain reaction (PCR)-fingerprinting by T3B, M13, and GACA, showed that the isolates were very similar but not identical. Both isolates had similar phenotypic characteristics and effectively produced melanin in their yeast forms, accounting for their ability of causing disease in a murine sporotrichosis model. Remarkably, isolate B was albino in its environmental form but caused more severe disease than the pigmented A isolate. These findings indicate that the patient was infected by two genetically and biologically distinct S. brasiliensis that vary in their production of melanin in their environmental forms. The results underscore the importance of characterizing phenotypically different isolates found in the same clinical specimen or patient.

Sections du résumé

BACKGROUND BACKGROUND
Sporotrichosis is a subcutaneous mycosis caused by dimorphic pathogenic fungi belonging to the Sporothrix genus. Pathogenic Sporothrix species typically produce melanin, which is known to be a virulence factor.
OBJECTIVES OBJECTIVE
The aim of this study was to perform phenotypic, genotypic, and virulence analyses of two distinct Sporothrix brasiliensis strains isolated from the same lesion on a patient from Rio de Janeiro.
METHODS AND FINDINGS RESULTS
Genotypic analyses by partial sequencing of the calmodulin, β-tubulin, and chitin synthase genes, as well as polymerase chain reaction (PCR)-fingerprinting by T3B, M13, and GACA, showed that the isolates were very similar but not identical. Both isolates had similar phenotypic characteristics and effectively produced melanin in their yeast forms, accounting for their ability of causing disease in a murine sporotrichosis model. Remarkably, isolate B was albino in its environmental form but caused more severe disease than the pigmented A isolate.
CONCLUSIONS CONCLUSIONS
These findings indicate that the patient was infected by two genetically and biologically distinct S. brasiliensis that vary in their production of melanin in their environmental forms. The results underscore the importance of characterizing phenotypically different isolates found in the same clinical specimen or patient.

Identifiants

pubmed: 31644705
pii: S0074-02762019000100350
doi: 10.1590/0074-02760190260
pmc: PMC6804372
pii:
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e190260

Références

Comp Med. 2013 Feb;63(1):29-37
pubmed: 23561935
Mycopathologia. 1980 Jul 1;71(2):73-83
pubmed: 6156415
Mycopathologia. 1990 Oct;112(1):19-22
pubmed: 2250689
Front Microbiol. 2017 Aug 23;8:1617
pubmed: 28878763
Comp Immunol Microbiol Infect Dis. 2013 Jul;36(4):425-32
pubmed: 23623733
PLoS One. 2016 Mar 31;11(3):e0152796
pubmed: 27031728
J Med Microbiol. 1999 Feb;48(2):195-203
pubmed: 9989648
J Clin Microbiol. 2007 Oct;45(10):3198-206
pubmed: 17687013
PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3110
pubmed: 25166475
Fungal Biol. 2016 Feb;120(2):246-64
pubmed: 26781380
Infect Immun. 2005 Sep;73(9):6147-50
pubmed: 16113337
FEMS Immunol Med Microbiol. 2008 Jun;53(1):72-8
pubmed: 18400010
Appl Environ Microbiol. 2012 Dec;78(24):8623-30
pubmed: 23042177
Rev Soc Bras Med Trop. 2014 May-Jun;47(3):392-3
pubmed: 25075494
Med Mycol. 2008 Sep;46(6):621-5
pubmed: 19180753
J Clin Microbiol. 2001 Oct;39(10):3505-11
pubmed: 11574564
Mem Inst Oswaldo Cruz. 2009 Aug;104(5):769-74
pubmed: 19820840
Cell Microbiol. 2003 Apr;5(4):203-23
pubmed: 12675679
Clin Infect Dis. 2015 Aug 15;61(4):663-4
pubmed: 25956895
Mycopathologia. 2011 Oct;172(4):257-67
pubmed: 21701792
Infect Immun. 2000 Jun;68(6):3696-703
pubmed: 10816530
Curr Opin Infect Dis. 2003 Apr;16(2):91-6
pubmed: 12734441
Mamm Genome. 2016 Jun;27(5-6):179-90
pubmed: 27126641
J Clin Microbiol. 1991 Jun;29(6):1106-13
pubmed: 1864926
J Clin Microbiol. 2012 Jun;50(6):2159-62
pubmed: 22403427
Emerg Infect Dis. 2011 Oct;17(10):1975-6
pubmed: 22000393
Int J Dermatol. 2003 Sep;42(9):677-81
pubmed: 12956676
Curr Opin Infect Dis. 2008 Apr;21(2):129-33
pubmed: 18317034

Auteurs

Manoel Marques E Oliveira (MME)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos, Rio de Janeiro, RJ, Brasil.

Rodrigo Almeida-Paes (R)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro, RJ, Brasil.

Danielly Corrêa-Moreira (D)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Taxonomia, Bioquímica e Bioprospecção de Fungos, Rio de Janeiro, RJ, Brasil.

Cintia de Moraes Borba (CM)

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Taxonomia, Bioquímica e Bioprospecção de Fungos, Rio de Janeiro, RJ, Brasil.

Rodrigo Caldas Menezes (RC)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos, Rio de Janeiro, RJ, Brasil.

Dayvison Francis Saraiva Freitas (DFS)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em Dermatologia Infecciosa, Rio de Janeiro, RJ, Brasil.

Antonio Carlos Francesconi do Valle (ACF)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em Dermatologia Infecciosa, Rio de Janeiro, RJ, Brasil.

Armando de Oliveira Schubach (AO)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Vigilância em Leishmaniose, Rio de Janeiro, RJ, Brasil.

Monica Bastos de Lima Barros (MBL)

Fundação Oswaldo Cruz-Fiocruz, Escola Nacional de Saúde Pública, Rio de Janeiro, RJ, Brasil.

Joshua D Nosanchuk (JD)

Albert Einstein College of Medicine, New York, United States of America.

Maria Clara Gutierrez-Galhardo (MC)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em Dermatologia Infecciosa, Rio de Janeiro, RJ, Brasil.

Rosely Maria Zancopé-Oliveira (RM)

Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro, RJ, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH